Case Study: Clinical Gamma-Delta T-Cell Therapies, Demonstrating Persistence & Durability for Positive Outcomes in Hematological & Solid Tumours

Time: 12:00 pm
day: Conference Day One


  • The first clinical data on gamma-delta T-cell therapies demonstrating persistence, durability and expansion in patients
  • Leveraging gamma-delta T-cell properties to evade the endogenous immune response
  • Intelligent engineering to maximise the tumor targeting ability of gamma-delta T-cells to bring cell therapies into solid tumours